Provided by Tiger Trade Technology Pte. Ltd.

ROCKET PHARMACEUTICALS INC C/WTS 02/09/2026 (TO PUR COM)

0.0300
+0.008539.53%
Volume:20.60K
Turnover:564.55
Market Cap:3.24M
PE:-0.01
High:0.0300
Open:0.0215
Low:0.0215
Close:0.0215
52wk High:0.0850
52wk Low:0.0066
Shares:107.90M
Float Shares:107.90M
Volume Ratio:0.48
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2474
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Jan 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 14, 2023

Major Issues Report

Form 8-K - Current report
Nov 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 02, 2023

Major Issues Report

Form 8-K - Current report
Sep 19, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Sep 16, 2023

Major Issues Report

Form 8-K - Current report
Sep 13, 2023

Major Issues Report

Form 8-K - Current report
Sep 12, 2023

Major Issues Report

Form 8-K - Current report
Aug 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 23, 2023

Major Issues Report

Form 8-K - Current report
May 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities